SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001504167-18-000016
Filing Date
2018-10-31
Accepted
2018-10-31 16:10:55
Documents
4
Period of Report
2018-10-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmx-20181031x8k.htm 8-K 37186
2 EX-10.1 bpmx-20181031ex10116425c.htm EX-10.1 732745
3 GRAPHIC bpmx20181031ex10116425c001.jpg GRAPHIC 30936
4 GRAPHIC bpmx20181031ex10116425c002.jpg GRAPHIC 89569
  Complete submission text file 0001504167-18-000016.txt   937344
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 181150424
SIC: 2834 Pharmaceutical Preparations